Gene Query: BMS1

Dataset Description Geneva Score
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 51.49
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 41.44
Genome wide expression change by RNF168 knocking down in NEC cells 39.76
Genes significantly down or Up-regulated upon RNF219 knockdown 31.84
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 27.07
R430: A potent inbibitor of DNA and RNA viruses 26.56
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 23.18
Developmental stage specific chromosome architecture in human erythroid cells 23.18
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 23.05
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 21.77
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 21.67
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 21.12
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 20.71
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 20.42
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 20.42
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 19.99
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 19.92
Genome wide miR-191 target profile determined by RIP and gene expression profiling 19.92
CD73 knockdown effect in pancreatic cancer cell lines 19.88
Regulation of highly expressed hCINAP on translatome 19.05
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 18.75
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 18.6
Triple vectors expand AAV transfer capacity in the retina 18.16
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 17.89
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 17.4
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 17.4
RNAseq Study in CC-671 Treated Cal-51 Cells 17.29
Differetially expressed genes after hTR overexpression in U2OS cells 16.7
Gene expression changes after LOC550643 silencing 16.69
FOXD3 is a novel tumor suppressor in lung cancer 16.47
Differential expression of genes in AD169-infected MRC5. 16.25
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 16.24
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 16.17
Downregulation of DDX5/DDX17 and REST 15.73
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 15.48
hTERT promotes cell adhesion and migration independent of telomerase activity 15.32
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 14.94
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 14.94
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 14.77
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 14.76
4sU-seq of HFF exposed to salt and heat stress 14.63
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 14.54
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 14.51
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 14.28
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 14.26
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 14.26
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 13.91
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 13.82
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 13.65
MYC dependent mRNA translation shapes gene expression and cell biology 13.53
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 13.49
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 13.37
RNA sequencing of GlyH-101-treated MCF-7 cell line 13.08
miR941 overexpression experiment 12.88
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 12.28
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 12.26
3’ Uridylation Expands miRNA Target Repertoire 12.17
High-throughput sequencing of PROMPT-enriched samples. 12.13
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 12.07
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 12.06
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 11.99
Genome wide expression change by RNF168 knocking down in MCF-7 cells 11.83
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 11.68
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 11.67
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 11.66
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 11.19
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 11.17
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 11.16
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 11.12
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 11.01
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 11.01
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 10.96
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 10.94
STRIPAK directs PP2A activity to promote oncogenic transformation 10.91
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 10.9
Expression level comparison under dividing and quiescent states in human primary fibroblasts 10.75
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 10.75
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 10.68
RNA transcriptome analysis during HSV-1 infection 10.57
IL-33 activates tumor stroma to promote intestinal polyposis 10.57
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 10.52
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 10.49
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.25
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 10.24
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 10.23
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 10.05
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 10.05
IMP3 regulated gene expression in breast cancer cells 10.0
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 9.98
The cohesin release factor WAPL restricts chromatin loop extension. 9.98
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 9.97
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 9.94
Nucleoporin-mediated regulation of cell identity genes 9.88
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 9.86
TCF7L1 knockdown in pancreatic cancer 9.83
AUF-1 affected genes in human skin cells 9.76
LNCaP treated with iBET 9.62
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 9.55
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 9.55
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 9.55
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 9.49
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 9.46
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 9.44
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 9.44
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 9.44
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 9.43
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 9.42
Differentially expressed vascular development genes for iPSC-ECs from CDI 9.24
The landscape of alternative splicing in aggressive prostate cancers 9.22
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 9.2
MicroRNA targetome analysis during HCMV infection 9.13
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 9.12
Human HAP1 cells before and after nutrient deprivation 9.12
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 9.1
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 9.09
LncRNA-GAS5 negative regulation of YAP-target genes expression 9.09
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 9.06
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 9.06
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 9.0
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 8.97
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 8.97
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 8.95
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 8.92
Chromatin landscape of human visceral and subcutaneous adipocytes 8.91
The evolution of N6-methyladenosine in primates 8.91
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.91
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 8.9
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 8.9
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 8.89
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 8.88
Pharmacologic inhibition of STAT5 in AML 8.76
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 8.76
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 8.73
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 8.71
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 8.67
Cajal bodies are linked to genome conformation 8.64
Cajal bodies are linked to genome conformation [RNA-Seq] 8.64
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 8.63
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 8.63
MEIS1 regulates hematopoiesis in hPSCs 8.63
A transcriptome dataset revealing the molecular features of breast cancer stem cells 8.58
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 8.58
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 8.58
SRSF1 role in cellular gene expression and splicing 8.55
Genome-wide discovery of human splicing branchpoints [RNAse] 8.43
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 8.41
RNA-seq analysis of BAP1-depleted uveal melanoma cells 8.41
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 8.39
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 8.35
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 8.33
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 8.32
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 8.24
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 8.24
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 8.19
RNA-seq analysis of RALD iPSCs after in vitro differentiation 8.15
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 8.1
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 8.09
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 8.08
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 8.08
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 8.08
SLAM-seq for K562 endogenous mRNA decay 8.07
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 8.06
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 8.03
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 8.02
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 8.0
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 7.93
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 7.9
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 7.9
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 7.89
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 7.78
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 7.76
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 7.75
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 7.75
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 7.73
RNA-seq of RKO cells with cTAZ KO or putback 7.71
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 7.69
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 7.68
Landscape and variation of RNA secondary structure across the human transcriptome 7.65
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 7.63
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 7.63
RNA-seq analysis of differentiating human erythroblasts 7.6
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 7.58
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 7.57
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 7.53
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.51
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 7.45
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 7.43
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.42
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 7.42
Molecular Criteria for Defining the Naive Human Pluripotent State 7.39
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 7.39
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 7.35
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 7.35
mRNA expression profile of Lymphocytes 7.34
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 7.32
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 7.28
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 7.27
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 7.26
RNA-seq of human aneuploid cell lines with Trisomy 21 7.2
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 7.15
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 7.13
Trans-differentiation of human adult peripheral blood T cells into neurons 7.11
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 7.09
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 7.07
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 7.06
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 7.02
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 6.91
The DPYSL2 gene connects mTOR and schizophrenia 6.89
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 6.86
Effect of PBK knockdown on C4-2 cell transcriptome 6.86
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 6.86
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 6.85
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 6.83
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 6.82
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.76
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 6.74
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 6.74
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 6.73
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 6.71
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 6.71
Transcriptome analysis upon C6orf203 silencing 6.65
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 6.64
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 6.58
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 6.53
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 6.52
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 6.48
Global Mapping of Human RNA-RNA Interactions 6.41
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 6.34
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 6.33
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 6.31
Identification of Sin3B regulated genes during quiescence 6.3
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 6.26
Co-regulation of splicing by Rbfox1 and hnRNP M 6.26
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 6.19
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 6.19
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 6.18
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 6.11
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 6.08
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 6.04
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 6.02
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 6.0
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 6.0
METTL3 and WTAP 5.98
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 5.93
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 5.93
Seletive inhibition of CDK9 in DLBCL cell lines 5.91
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 5.89
Splicing and epigenetic factors jointly regulate epidermal differentiation 5.89
m6A-dependent regulation of messenger RNA stability 5.84
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 5.83
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 5.8
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 5.8
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 5.8
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 5.8
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 5.78
Capturing the Interactome of Newly Transcribed RNA 5.78
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.78
Conservative alteration of chromosomal expression pattern across human solid tumor types 5.75
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 5.71
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 5.58
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 5.53
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 5.52
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 5.48
scRNASeq analysis of cycling cardiomyocytes 5.39
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.36
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.36
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 5.34
Regulating Interleukin-2 activity with engineered receptor signaling clamps 5.32
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 5.3
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 5.26
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 5.24
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 5.18
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 5.16
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 5.15
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.12
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 5.09
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 5.08
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 5.05
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 5.03
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 5.02
Solid phase chemistry to covalently and reversibly capture thiolated RNA 4.98
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 4.97
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 4.97
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 4.93
Derivation and differentiation of haploid human embryonic stem cells 4.92
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 4.9
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 4.9
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.87
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 4.85
Human Treg IFNg/IL-10 subpopulations 4.84
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 4.83
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 4.82
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 4.82
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 4.82
Efficient and quantitative high-throughput tRNA sequencing 4.76
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 4.72
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.7
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 4.67
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 4.67
Primary Human B-cell Temporal Response to CD40L Stimulation 4.64
K562 polyA RNA-Seq 4.59
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 4.54
Profiling of escape kinetics of viruses subjected to RNAi 4.43
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 4.4
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 4.34
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.32
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 4.23
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 4.23
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 4.2
Differential Protein Occupancy Profiling of the mRNA Transcriptome 4.2
Human Treg NaCl stimulation 4.17
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 4.16
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 4.16
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 4.13
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 4.1
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 4.06
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 4.01
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.93
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.93
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 3.91
Mapping interactions for the TNIP2 hub protein 3.91
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 3.91
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.87
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 3.84
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 3.84
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 3.82
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 3.75
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 3.72
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 3.66
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.65
The Genetic Landscape of Diamond-Blackfan Anemia 3.65
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 3.63
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 3.59
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 3.58
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 3.58
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.58
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.51
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 3.5
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 3.5
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 3.49
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.46
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.45
TOP2B disturbed the quality of human oocytes with advanced maternal age 3.43
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 3.38
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 3.34
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 3.34
In vitro modeling of human germ cell development using pluripotent stem cells 3.29
Gene expression signatures of innate lymphoid cells from human blood 3.2
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.2
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 3.19
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.19
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 3.11
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 3.08
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 3.06
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.04
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.04
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 3.01
Ribosome profiling upon inhibition of eIF4A 3.0
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 2.99
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 2.95
Transcriptome-wide response to synthetic chromatin protein PcTF 2.93
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 2.92
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 2.92
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 2.88
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 2.88
RNA seq with AML (NB4) cells upon FTO inhibition 2.88
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 2.83
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.81
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 2.78
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 2.73
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.69
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.69
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 2.63
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 2.62
Transcriptome of U251 cells overexpression complement component 7 2.6
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.52
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 2.51
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 2.51
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.51
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.45
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.43
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.42
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.4
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.4
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 2.34
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 2.33
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 2.32
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.3
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 2.3
Gene expression changes due to PARP knockdown in human cells 2.3
Primate-specific gene TMEM14B promotes cortical expansion and folding 2.28
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.25
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.25
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.19
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.12
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 2.1
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.05
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 2.04
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 2.04
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.01
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.98
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.98
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.97
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.97
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.94
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 1.92
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.91
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 1.8
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.78
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.78
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.78
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 1.77
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.72
High-resolution comparative analysis of great ape genomes 1.71
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 1.65
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.63
Transposon-based construction of strand-specific RNA-seq libraries 1.63
6mer seed toxicity in viral microRNAs 1.58
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.57
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.57
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 1.54
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.46
Exploring ILF2 regulatory genes by next-generation sequencing 1.44
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.41
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.37
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.35
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 1.33
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.32
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.28
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.27
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.27
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.24
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.22
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.21
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.19
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.12
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.02
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.99
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.96
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.96
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.92
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.9
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.9
Modulation of nonsense-mediated decay by rapamycin 0.88
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.86
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.86
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.86
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.86
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.82
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.81
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.79
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.79
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.77
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.77
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.76
Impact on erythroid progenitor type on erythroid differntiation 0.7
Effect of ILF3 on translation during homeostasis and the antiviral response 0.69
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.67
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.67
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.67
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.66
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.59
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.57
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.57
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.55
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.53
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.53
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.51
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.49
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.43
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.42
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.42
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.4
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.37
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.35
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.32
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.32
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.31
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.29
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.24
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.23
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.22
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.21
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.2
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.19
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.18
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.14
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.12
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.09
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.09
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.09
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.07
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.06
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.06
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.05
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.03
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.03
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.02
The contribution of Alu exons to the human proteome 0.02
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation